Lysatpharma GmbH
PrivateLast Round
Seed
Jan 1, 2020
Company Overview
Lysatpharma GmbH is a biotechnology company that develops novel therapeutic approaches for the treatment of acute and chronic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
regenerative medicineimmunotherapyextracellular vesiclesexosomesbiologicsexosome therapyinflammatory diseasesautoimmune diseasescell-free therapydrug developmentneurodegenerative diseasesgraft-versus-host diseaseGvHDrheumatoid arthritismultiple sclerosispre-clinical researchamyotrophic lateral sclerosisALSpharma licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lysatpharma GmbH Comparables
Compare Lysatpharma GmbH with similar companies based on industry and business-model similarity.
Lysatpharma GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 1, 2020 |
Lysatpharma GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xlife Sciences AG | Seed |
Lysatpharma GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lysatpharma GmbH's valuation, stock price, and market status.